A proposed merger

Arrow and Apotex have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations The proposed merger between Arrow Pharmaceuticals and Apotex is still subject to several conditions, including ACCC approval and due diligence, and is anticipated for completion in the new financial year. According to a statement released late Wednesday